ArticleFrontiers in epigenetics and epigenomics2025
Pioneers of chromosome elimination.
Article in Frontiers in epigenetics and epigenomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epigenetic traits are persistent cellular and organismal properties that do not result from changes in DNA sequence. One such property involves transmission of chromosomes, which entails the formation of highly specialized chromatin structures, the kinetochores, on selected chromosomal regions, called centromeres. Centromere function is essential and centromeres are determined epigenetically by the deposition of a variant histone H3 CENP-A (CENH3 in plants). Either reduced or ectopic function alone leads to genome instability, decreased fitness, aneuploid syndromes, and cancer. At times, however, centromeres malfunction in an apparently programmed mode. This is exemplified by a peculiar centromeric syndrome involving selective elimination of a chromosome set, which can affect a wide range of organisms, including plants. Over half a century ago, plant geneticists described this syndrome in interspecific crosses of barley. Building on their work, we examine the growing understanding of how CENH3 function can be modified to affect epigenetic regulation of centromeres.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.